1. Home
  2. VACI vs CADL Comparison

VACI vs CADL Comparison

Compare VACI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VACI

Viking Acquisition Corp. I Class A Ordinary Shares

N/A

Current Price

$10.07

Market Cap

311.1M

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.10

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VACI
CADL
Founded
2025
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.1M
339.8M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
VACI
CADL
Price
$10.07
$6.10
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.43
AVG Volume (30 Days)
53.3K
731.5K
Earning Date
01-01-0001
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.86
$4.25
52 Week High
$10.07
$13.68

Technical Indicators

Market Signals
Indicator
VACI
CADL
Relative Strength Index (RSI) 80.18 54.31
Support Level $9.86 $5.91
Resistance Level $9.94 $6.62
Average True Range (ATR) 0.03 0.36
MACD 0.02 0.00
Stochastic Oscillator 100.00 52.97

Price Performance

Historical Comparison
VACI
CADL

About VACI Viking Acquisition Corp. I Class A Ordinary Shares

Viking Acquisition Corp I is a blank check company.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: